Description: ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. Its products include GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
Home Page: www.alk.net
BOege AllE 6-8
Horsholm,
2970
Denmark
Phone:
45 45 74 75 76
Officers
| Name | Title |
|---|---|
| Mr. Claus Steensen Solje | Executive VP, CFO & Member of Management Board |
| Mr. Søren Daniel Niegel | Executive VP of Commercial Operations & Member of Management Board |
| Dr. Henriette Mersebach | Executive VP Research & Development & Member of Management Board |
| Ms. Katja Barnkob Thalund | Project Director of Global CMC Development & Employee-elected Director |
| Ms. Lise Lund Maerkedahl | Project Director of Global Research & Employee-elected Director |
| Mr. Peter Halling | President & CEO |
| Mr. Per Plotnikof | VP of Corporate Communications, Investor Relations & Strategic Planning and Head of IR |
| Jacob Glenting | Senior Vice President of Global Strategy & Corporate Development |
| Ms. Lika Thiesen | Executive Vice President of Global People & Organisation |
| Prof. Hendrik Kees Kam Nolte M.D., Ph.D. | Senior Vice President of Research & Development - North America and International Markets |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 45 |
| Price-to-Book MRQ: | 6.8129 |
| Price-to-Sales TTM: | 6.5682 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2824 |